Metropolitan Life Insurance Company (MetLife)’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,974
| Closed | -$40.8K | – | 730 |
|
|
2024
Q1 | $40.8K | Buy |
1,974
+528
| +37% | +$10.9K | ﹤0.01% | 1511 |
|
|
2023
Q4 | $33.4K | Hold |
1,446
| – | – | ﹤0.01% | 1647 |
|
|
2023
Q3 | $11.6K | Hold |
1,446
| – | – | ﹤0.01% | 2151 |
|
|
2023
Q2 | $12.6K | Buy |
+1,446
| New | +$12.6K | ﹤0.01% | 2177 |
|
|
2022
Q4 | – | Sell |
-1,753
| Closed | -$13.9K | – | 2356 |
|
|
2022
Q3 | $13.9K | Hold |
1,753
| – | – | ﹤0.01% | 2189 |
|
|
2022
Q2 | $13.8K | Hold |
1,753
| – | – | ﹤0.01% | 2223 |
|
|
2022
Q1 | $21.3K | Sell |
1,753
-4,369
| -71% | -$53.1K | ﹤0.01% | 2060 |
|
|
2021
Q4 | $74.9K | Buy |
+6,122
| New | +$74.9K | ﹤0.01% | 2613 |
|